James Paul Maynard MD

PubMed

• 10 citations
  Safety and pharmacodynamics of a single infusion of danavorexton in adults with obstructive sleep apnea experiencing excessive daytime sleepiness despite adequate use ...
  Richard K Bogan, James P Maynard, Rachel Neuwirth, Hélène Faessel, Todd Swick
  Sleep Medicine. 2023-07-01
• 19 citations
  Efficacy of atomoxetine plus oxybutynin in the treatment of obstructive sleep apnea with moderate pharyngeal collapsibility.
  Paula K Schweitzer, James P Maynard, Paul E Wylie, Helene A Emsellem, Scott A Sands
  Sleep & Breathing = Schlaf & Atmung. 2023-05-01
• 21 citations
  A Pivotal Study to Validate the Performance of a Novel Wearable Sensor and System for Biometric Monitoring in Clinical and Remote Environments.
  Ellora Sen-Gupta, Donald E. Wright, James W. Caccese, John A. Wright, Elise Jortberg
  Digital Biomarkers. 2019-03-01

Journal Articles

• Efavirenz modulation of sleep spindles and sleep spectral profile  
  Simen AA, Ma J, Svetnik V, Mayleben D, Maynard J, Roth A, Mixson L, Mogg R, Shera D, George L, Mast TC, Beals C, Stoch A, Struyk A, Shire N, Fraiser L, Journal of sleep research, 1/1/2016
• Pharmacokinetics, pharmacodynamics and safety of CEP-26401, a high-affinity histamine-3 receptor antagonist, following single and multiple dosing in healthy subjects  
  Spiegelstein O, Stevens J, Van Gerven J, Nathan PJ, Maynard JP, Mayleben DW, Hellriegel E, Yang R,, Journal of Psychopharmacology, 1/1/2016